Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

EYPT Relative to the S&P 500

EYPT Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the EyePoint Pharmaceuticals, Inc. (NASD:EYPT) seasonal charts above shows that a Buy Date of June 26 and a Sell Date of September 21 has resulted in a geometric average return of 0.52% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 20.82% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

EyePoint Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

To download EYPT seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: EYPT